Zacks Research Issues Negative Outlook for Chemours Earnings
The Chemours Company (NYSE:CC – Free Report) – Investment analysts at Zacks Research decreased their Q2 2025 EPS estimates for Chemours in a research note issued to investors on Monday, May 19th. Zacks Research analyst R. Department now forecasts that the specialty chemicals company will earn $0.47 per share for the quarter, down from their […]
The Chemours Company (NYSE:CC – Free Report) – Investment analysts at Zacks Research decreased their Q2 2025 EPS estimates for Chemours in a research note issued to investors on Monday, May 19th. Zacks Research analyst R. Department now forecasts that the specialty chemicals company will earn $0.47 per share for the quarter, down from their […]
